Literature DB >> 11346851

Midodrine for the management of orthostatic hypotension in patients with spinal cord injury: A case report.

J Mukand1, L Karlin, K Barrs, P Lublin.   

Abstract

A 21-year-old man sustained anterior displacement and a burst fracture of C7 in a motor vehicle crash. He underwent anterior corpectomy, decompression, fusion of C6-T1 vertebrae, and halo placement. The American Spinal Injury Association grade of his spinal cord injury (SCI) was C6 C tetraplegia. Severe orthostatic hypotension in the upright position complicated the patient's rehabilitation program. Midodrine was prescribed, and other medications with possible adverse effects were adjusted. Significant improvement after taking midodrine was reflected in the orthostatic vital signs and symptoms, as well as in FIM instrument scores. Staff noted improvements with therapy participation and functional status. The patient tolerated the midodrine well and had no significant side effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11346851     DOI: 10.1053/apmr.2001.22350

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  9 in total

Review 1.  Role of vasopressor administration in patients with acute neurologic injury.

Authors:  Katie M Muzevich; Stacy A Voils
Journal:  Neurocrit Care       Date:  2009-04-22       Impact factor: 3.210

2.  Improvements in orthostatic instability with stand locomotor training in individuals with spinal cord injury.

Authors:  Susan J Harkema; Christie K Ferreira; Rubia J van den Brand; Andrei V Krassioukov
Journal:  J Neurotrauma       Date:  2008-12       Impact factor: 5.269

3.  Effect of Alpha-1-Adrenergic Agonist, Midodrine for the Management of Long-Standing Neurogenic Shock in Patient with Cervical Spinal Cord Injury: A Case Report.

Authors:  Taikwan Kim; Cheol Su Jwa
Journal:  Korean J Neurotrauma       Date:  2015-10-31

4.  Lessons learned from the pilot study of an orthostatic hypotension intervention in the subacute phase following spinal cord injury.

Authors:  Bastien Moineau; Andrea Brown; Louise Brisbois; Vera Zivanovic; Masae Miyatani; Naaz Kapadia; Jane T C Hsieh; Milos R Popovic
Journal:  J Spinal Cord Med       Date:  2019-10       Impact factor: 1.985

5.  Normalization of supine blood pressure after nitric oxide synthase inhibition in persons with tetraplegia.

Authors:  Jill M Wecht; Joseph P Weir; AnnMarie H Krothe; Ann M Spungen; William A Bauman
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

Review 6.  A systematic review of the management of orthostatic hypotension after spinal cord injury.

Authors:  Andrei Krassioukov; Janice J Eng; Darren E Warburton; Robert Teasell
Journal:  Arch Phys Med Rehabil       Date:  2009-05       Impact factor: 3.966

Review 7.  Vascular dysfunctions following spinal cord injury.

Authors:  Constantin Popa; Florian Popa; Valentin Titus Grigorean; Gelu Onose; Aurelia Mihaela Sandu; Mihai Popescu; Gheorghe Burnei; Victor Strambu; Crina Sinescu
Journal:  J Med Life       Date:  2010 Jul-Sep

Review 8.  Cardiac dysfunctions following spinal cord injury.

Authors:  Valentin Titus Grigorean; Aurelia Mihaela Sandu; Mihai Popescu; Mihai Aurelian Iacobini; Rares Stoian; Catalin Neascu; Victor Strambu; Florian Popa
Journal:  J Med Life       Date:  2009 Apr-Jun

9.  Management of Hypotension and Bradycardia Caused By Spinal Cord Injury. The Usefulness of Midodrine and Methylxanthines.

Authors:  Mojtaba Mojtahedzadeh; Hamidreza Taghvaye-Masoumi; Atabak Najafi; Mehrnoush Dianatkhah; Hamidreza Sharifnia; Maryam Shahrokhi
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.